{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-227478","form_type":"8-K","ticker":"KALV","cik":"0001348911","company_name":"KalVista Pharmaceuticals, Inc.","filed_at":"2025-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.208830+00:00","generated_at":"2026-05-17T04:54:42.988768+00:00","sec_items":["5.02","5.07","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"KalVista appoints Bethany Sensenig to Board and Audit Committee; annual meeting results filed","bullets":["Bethany Sensenig appointed to Board and Audit Committee effective October 1, 2025.","Sensenig is CFO and Head of Operations at Radius Health; former Biogen VP of Finance.","Nancy Stuart moves off Audit Committee but remains on Board and joins Compensation Committee.","Stockholders re-elected Benjamin Palleiko and Brian Pereira as Class I directors for three-year terms.","Advisory vote on named executive officer compensation passed with 33.6M shares for vs 4.0M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-227478","json":"https://secwatch.observer/filing/0001193125-25-227478.json","markdown":"https://secwatch.observer/filing/0001193125-25-227478.md","text":"https://secwatch.observer/filing/0001193125-25-227478.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348911/000119312525227478/0001193125-25-227478-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348911/000119312525227478/d945945d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:54:42.988768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}